These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22833948)

  • 1. Antileishmanial activity of nanocurcumin.
    Samim M; Naqvi S; Arora I; Ahmad FJ; Maitra A
    Ther Deliv; 2011 Feb; 2(2):223-30. PubMed ID: 22833948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
    Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and Characterization of a Self-Emulsifying Drug Delivery System (SEDDS) of Curcumin for the Topical Application in Cutaneous and Mucocutaneous Leishmaniasis.
    Khan M; Nadhman A; Sehgal SA; Siraj S; Yasinzai MM
    Curr Top Med Chem; 2018; 18(18):1603-1609. PubMed ID: 30360717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies.
    Want MY; Islamuddin M; Chouhan G; Dasgupta AK; Chattopadhyay AP; Afrin F
    J Colloid Interface Sci; 2014 Oct; 432():258-69. PubMed ID: 25086720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage specific drug delivery in experimental leishmaniasis.
    Basu MK; Lala S
    Curr Mol Med; 2004 Sep; 4(6):681-9. PubMed ID: 15357216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
    Afzal I; Sarwar HS; Sohail MF; Varikuti S; Jahan S; Akhtar S; Yasinzai M; Satoskar AR; Shahnaz G
    Nanomedicine (Lond); 2019 Feb; 14(4):387-406. PubMed ID: 30688557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicines for Therapy of Visceral Leishmaniasis.
    Want MY; Yadav P; Afrin F
    J Nanosci Nanotechnol; 2016 Mar; 16(3):2143-51. PubMed ID: 27455613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
    Chaubey P; Patel RR; Mishra B
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis.
    Corpas-López V; Díaz-Gavilán M; Franco-Montalbán F; Merino-Espinosa G; López-Viota M; López-Viota J; Belmonte-Reche E; Pérez-Del Palacio J; de Pedro N; Gómez-Vidal JA; Morillas-Márquez F; Martín-Sánchez J
    Pharmacol Res; 2019 Jan; 139():375-383. PubMed ID: 30503838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
    Chaubey P; Mishra B; Mudavath SL; Patel RR; Chaurasia S; Sundar S; Suvarna V; Monteiro M
    Int J Biol Macromol; 2018 May; 111():109-120. PubMed ID: 29307805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.
    Bisht S; Feldmann G; Soni S; Ravi R; Karikar C; Maitra A; Maitra A
    J Nanobiotechnology; 2007 Apr; 5():3. PubMed ID: 17439648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purely aqueous PLGA nanoparticulate formulations of curcumin exhibit enhanced anticancer activity with dependence on the combination of the carrier.
    Nair KL; Thulasidasan AK; Deepa G; Anto RJ; Kumar GS
    Int J Pharm; 2012 Apr; 425(1-2):44-52. PubMed ID: 22266528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.
    Tavares GSV; Mendonça DVC; Miyazaki CK; Lage DP; Soyer TG; Carvalho LM; Ottoni FM; Dias DS; Ribeiro PAF; Antinarelli LMR; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
    Parasitol Int; 2019 Feb; 68(1):63-72. PubMed ID: 30339837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis.
    Italia JL; Kumar MN; Carter KC
    J Biomed Nanotechnol; 2012 Aug; 8(4):695-702. PubMed ID: 22852479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis.
    Mendonça DVC; Martins VT; Lage DP; Dias DS; Ribeiro PAF; Carvalho AMRS; Dias ALT; Miyazaki CK; Menezes-Souza D; Roatt BM; Tavares CAP; Barichello JM; Duarte MC; Coelho EAF
    Exp Parasitol; 2018 Mar; 186():24-35. PubMed ID: 29448040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
    Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
    Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model.
    Durand R; Paul M; Rivollet D; Fessi H; Houin R; Astier A; Deniau M
    Parasite; 1997 Dec; 4(4):331-6. PubMed ID: 9587601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis.
    Tempone AG; Mortara RA; de Andrade HF; Reimão JQ
    Int J Antimicrob Agents; 2010 Aug; 36(2):159-63. PubMed ID: 20554161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
    Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.